Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Liver Neoplasms × Idarubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 36 Leukemia 15 Congenital Abnormalities 9 Leukemia, Monocytic, Acute 8 Leukemia, Myelomonocytic, Acute 7 Leukemia, Megakaryoblastic, Acute 6 Leukemia, Erythroblastic, Acute 6 Myelodysplastic Syndromes 5 Recurrence 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia, Eosinophilic, Acute 3 Anemia, Refractory, with Excess of Blasts 3 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Basophilic, Acute 2 Neoplasms 1 Myeloproliferative Disorders 1 Liver Neoplasms 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Biphenotypic, Acute 1 Childhood Acute Promyelocytic Leukemia With PML-RARA 1

Interventions

Sorafenib 22 Bevacizumab 10 Capecitabine 6 Radiofrequency Ablation 5 Oxaliplatin 5 Fluorouracil 5 Doxorubicin 5 pembrolizumab 4 Sunitinib 4 Radiosurgery 4 Cisplatin 4 Ramucirumab 3 Radiotherapy 3 Leucovorin 3 Erlotinib Hydrochloride 3 Carboplatin 3 tremelimumab 2 spartalizumab 2 perflutren 2 derazantinib 2 carotuximab 2 Nivolumab 2 Mitomycin 2 Magnetic Resonance Spectroscopy 2 Magnetic Resonance Imaging 2 Ipilimumab 2 Immunohistochemistry 2 Gemcitabine 2 Folfox protocol 2 Fluorodeoxyglucose F18 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02185768 2025-07-04

IDASPHERE II

Federation Francophone de Cancerologie Digestive

Phase 2 Completed

46 enrolled 11 charts

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡